Abstract:Background: Recently, several studies have suggested that abnormal quantity and function of regulatory T cells (Tregs) may play a vital role in the development of rheumatoid arthritis (RA). CD25+FOXP3+ T cells include CD4+ (CD4+ Tregs) and CD8+ cells (CD8+ Tregs). Recently studies have shown that CD8+ Tregs also have immunosuppressive function, similar to even stronger than CD4+ Tregs, and are more sensitive to IL-2 in vivo. However, the status of CD8+Treg cells in RA is unknown. Objectives: Our study was designed to clarify the level of CD4-CD25+FOXP3+ T cells in RA patients, and to investigate the role of low-dose interleukin-2 (IL-2) therapy in the regulation of CD4-CD25+FOXP3+ T cells in RA patients to provide another theoretical basis besides CD4+ Tregs to IL-2 therapy. Methods: Three hundred and four RA patients (diagnosis according to the 2010 ACR criteria) were enrolled; no treatment group (N = 75), DMARDs treatment group (N = 73), low dose IL-2 treatment group (50WIU/day × 5 days, subcutaneous injection) (N = 156), and healthy control group (N = 90). The absolute numbers of CD4-CD25+FOXP3+ T cells in peripheral blood were detected by flow cytometry. We assumed that CD4- T cells with CD25+ and FOXP3+ were mostly CD8+CD25+FOXP3+ Treg cells, which was CD4-CD25+FOXP3+ T cells in this study. The levels of CD4-CD25+FOXP3+ T cells among these groups were compared with that of health group or each other respectively, and then the statistical software SPSS 20.0 was used for analysis; p<0.05 was considered significant. Results: As compared with the healthy group, the absolute number of CD4-CD25+FOXP3+ T cells decreased significantly in the untreated RA patients [0.94(0.41,1.61) vs 1.31(0.72,2.52), P<0.001] and more dramatically in DMARDs treatment patients [0.86(0.36,1.83) vs 1.31(0.72,2.52), P<0.01]. After treatment with IL-2, the absolute count of CD4-CD25+FOXP3+ T cells increased significantly compared with that before treatment [0.91(0.48,1.54) vs 2.10(1.12,3.56), P<0.001]. Conclusions: The absolute number of CD4-CD25+FOXP3+ T cells in untreated RA patients were lower than those health, implying that CD4-CD25+FOXP3+ T cells deficiency was caused by disease itself but not immunosuppressive therapy, which may be an important factor in the pathogenesis of RA. The traditional DMARDs therapy did not improve this reduction. Low dose IL-2 can increase the absolute number of CD4-CD25+FOXP3+ T cells in peripheral blood. We are about to detect the number of CD8+CD25+FOXP3+ Treg cells accurately to verify this theory. Disclosure of Interest: None declared

Cutting Edge: All-Trans Retinoic Acid Sustains the Stability and Function of Natural Regulatory T Cells in an Inflammatory Milieu.

Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions

Atra Restores the Stability and Functionality of Ntregs in the Inflammatory Milieu

Critical role of all-trans retinoic acid in stabilizing human nTregs under inflammatory conditions (P5133)

All-Trans Retinoic Acid Promotes Tgf-Beta-Induced Tregs Via Histone Modification But Not Dna Demethylation On Foxp3 Gene Locus

The role of all-trans retinoic acid in the biology of Foxp3+ regulatory T cells

TGF-β-induced CD4+ Regulatory T Cells but Not Ntregs Ameliorate Autoimmune Arthritis by Shifting the Balance Between Tregs and Th17 Cells in Vivo (179.14)

Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance.

Characterization of Protective Human CD4CD25 FOXP3 Regulatory T Cells Generated with IL-2, TGF-β and Retinoic Acid.

All-Trans Retinoic Acid Induces CD4+CD25+FOXP3+ Regulatory T Cells by Increasing FOXP3 Demethylation in Systemic Sclerosis CD4+ T Cells.

SAT0213 Low Dose Il-2 Restores Decreased Absolute Number of Regulatory T Cells and Imbalance Between Th17 and Regulatory T Cells in Patients with Rheumatoid Arthritis

Differential Role of All-Trans Retinoic Acid in Promoting the Development of CD4+ and CD8+ Regulatory T Cells.

Therapeutic Effects of TGF-β-induced Itregs on Established Autoimmune Diseases (115.3)

All-trans retinoic acid alleviates collagen-induced arthritis and promotes intestinal homeostasis

SAT0163 Absolute Number of Peripheral Cd4-Cd25+foxp3+t Cells Decreases and Restores after Low-Dose Interleukin-2 Treatment in Rheumatoid Arthritis

Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells.

Treg-targeted efficient-inducible platform for collagen-induced arthritis treatment

Therapeutic Effect of Exogenous Regulatory T Cells on Collagen-induced Arthritis and Rheumatoid Arthritis

All-trans Retinoic Acid Attenuates Airway Inflammation by Inhibiting Th2 and Th17 Response in Experimental Allergic Asthma

Restoring Oxidant Signaling Suppresses Proarthritogenic T Cell Effector Functions in Rheumatoid Arthritis.

TGF-β-induced CD4+ FoxP3+ Regulatory T Cell-Derived Extracellular Vesicles Modulate Notch1 Signaling Through Mir-449A and Prevent Collagen-Induced Arthritis in a Murine Model.